Symptomatic hypoglycemia related to inappropriately high igf-ii serum levels in a patient with desmoplastic small round cell tumor (2010)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.1155/2010/684045
- Subjects: HIPOGLICEMIA; BIÓPSIA; NEOPLASIAS (DIAGNÓSTICO); NEOPLASIAS (QUIMIOTERAPIA;RADIOTERAPIA); IMUNOHISTOQUÍMICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Case reports in medicine
- ISSN: 1687-9627
- Volume/Número/Paginação/Ano: v. 2010, Art. 684045, 2010
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BARRA, Willimas Fernandes et al. Symptomatic hypoglycemia related to inappropriately high igf-ii serum levels in a patient with desmoplastic small round cell tumor. Case reports in medicine, v. 2010, 2010Tradução . . Disponível em: https://doi.org/10.1155/2010/684045. Acesso em: 21 fev. 2026. -
APA
Barra, W. F., Castro Jr., G., Hoff, A. O., Siqueira, S. A. C., & Hoff, P. M. (2010). Symptomatic hypoglycemia related to inappropriately high igf-ii serum levels in a patient with desmoplastic small round cell tumor. Case reports in medicine, 2010. doi:10.1155/2010/684045 -
NLM
Barra WF, Castro Jr. G, Hoff AO, Siqueira SAC, Hoff PM. Symptomatic hypoglycemia related to inappropriately high igf-ii serum levels in a patient with desmoplastic small round cell tumor [Internet]. Case reports in medicine. 2010 ; 2010[citado 2026 fev. 21 ] Available from: https://doi.org/10.1155/2010/684045 -
Vancouver
Barra WF, Castro Jr. G, Hoff AO, Siqueira SAC, Hoff PM. Symptomatic hypoglycemia related to inappropriately high igf-ii serum levels in a patient with desmoplastic small round cell tumor [Internet]. Case reports in medicine. 2010 ; 2010[citado 2026 fev. 21 ] Available from: https://doi.org/10.1155/2010/684045 - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
Informações sobre o DOI: 10.1155/2010/684045 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
